Join us for an insightful webinar exploring the transformative impact of digitalization and automation on pharmaceutical R&D and manufacturing. Discover how cutting-edge data capture, centralization, and standardization techniques are creating AI-ready data, paving the way for groundbreaking advancements in drug discovery, development, and production. We’ll also delve into how automating traditionally manual tasks enhances efficiency, minimizes errors, and ensures seamless data flow between R&D and manufacturing. This accelerates the delivery of personalized medicines while significantly reducing costs.
Learn how well integrated digital solutions can drive your digital transformation and optimize your R&D and manufacturing processes!
November 20, 2024 | 11:00 a.m. EST
Anna Codina, Ph.D.
Senior Director Strategy and Business Development, SciYAnna Codina is Senior Director of Strategy and Business Development at SciY, where she focuses on enabling data-driven orchestration across the pharmaceutical value chain. With a background in experimental science, analytical development, and digital innovation, she works at the intersection of data, automation, and AI to accelerate scientific workflows and decision-making.
Anna holds a Ph.D. in protein NMR from the University of Barcelona and completed postdoctoral research at the MRC Laboratory of Molecular Biology in Cambridge. She spent seven years in Analytical R&D at Pfizer, specializing in reaction monitoring, impurity characterization, and regulatory submissions, and was recognized with a Pfizer Worldwide Achievement Award for implementing NMR-based reaction monitoring in an open-access environment.
Since joining Bruker, Anna has held multiple leadership roles across applications, product management, and biopharma business development and market management. In her current role at SciY, she drives strategy for vendor-agnostic data platforms and digital solutions that connect instruments, robotics, and enterprise systems enabling orchestration, AI-powered experimentation and scalable workflows across R&D, CROs/CDMOs, and manufacturing.